Skip to main content
. 2015 Nov 10;6:260. doi: 10.3389/fphar.2015.00260

Table 2.

Clinical and laboratory toxicity.

Placebo period (D1–D2) Single-dose period (D15–D16) Repeated-dose period (D22–D30)
n (%) e n (%) e n (%) e
Dry pharynx 4 36 7
Sore throat 8 73 22
Throat burning 4 36 12
Headache 5 45 8
Jaw pain 1 9 1
Neck pain 2 18 3
Dizziness 3 27 3 2 18 5
Poor sleep 4 36 4
Palpitation 2 18 2
Chest stuffiness 3 27 5
Fatigue 1 9 1
Nausea 1 9 1
Skin needling sensation 3 27 3
Skin burning sensation 3 27 8
Limb numbness 4 36 9
Limb pain 1 9 1
Thirsty 1 9 1
ALT 4 36 8
AST 4 36 8

n, Number of subjects; e, number of adverse events; %, proportion of subjects having the event.